Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1994-05-03
2000-04-11
Moezie, Minna
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
514824, A61K 3105
Patent
active
060489030
ABSTRACT:
The level of heavy density lipoproteins (HDL) in the blood of a human subject can be in eased by administering dosages of between 50 and 1,000 milligrams of trans-resveratrol to the subject daily. This same dosage reduces the level of light density lipoproteins (LDL) in the blood of the subject. By increasing the blood level of HDL and decreasing the blood level of LDL in the subject, the risk of hypercholesterolemia in the subject is reduced.
REFERENCES:
"Ethanol Stimulates Apolpoprotein A-I Secretion by Human Hepatocytes: Implications for a mechanism for Atheroscleroisis Protection", Metabolism vol. 41,#8, Aug. 1992, pp. 827-832.
Chemical Abstracts 116: 254401 (1992), Siemann et al.
Chemical Abstracts 103: 70127 (1985), JP 60009455.
Chemical Abstracts 97: 85090 (1982), Arichi et al.
Moezie Minna
Thomas Charles H.
Toppo Robert
Toppo Shaina
LandOfFree
Treatment for blood cholesterol with trans-resveratrol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for blood cholesterol with trans-resveratrol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for blood cholesterol with trans-resveratrol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177167